February 12, 2019

Gornitzky represented the underwriters, led by Oppenheimer & Co., in the USD 15.4 million follow-on offering of BioLineRx Ltd.

Gornitzky represented the underwriters, led by Oppenheimer & Co., in the USD 15.4 million follow-on offering of American Depositary Shares (ADSs) and warrants of BioLineRx Ltd. on the NASDAQ Capital Market.

BioLineRx is a clinical-stage bio-pharmaceutical company focused on oncology and immunology.

Oppenheimer & Co. acted as sole book-running manager for the offering. Maxim Group acted as co-manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Neta Peled (Associate).

RELATED NEWS & PUBLICATIONS

Hit enter to search or ESC to close